Last $6.14 USD
Change Today +0.27 / 4.60%
Volume 1.2M
CYTK On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert I. Blum

Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern, Cytokinetics, Incorporated
AgeTotal Calculated CompensationThis person is connected to 29 board members in 1 different organizations across 1 different industries.

See Board Relationships
50$1,322,750
As of Fiscal Year 2013

Background*

Mr. Robert I. Blum has been President and Chief Executive Officer of Cytokinetics, Incorporated since January 2007. Mr. Blum previously served as President from February 2006 to January 2007, Executive Vice President, Corporate Development and Commercial Operations and Chief Business Officer from September 2004 to February 2006, Executive Vice President, Corporate Development and Finance and Chief Financial Officer from January 2004 to September 2004, Senior Vice President, ...

Read Full Background

Corporate Headquarters*

280 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-624-3000
Fax: 650-624-3010

Board Members Memberships*

2007-Present
Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern

Education*

BA
The Leland Stanford Junior University
MBA
Harvard Business School

Other Affiliations*

Annual Compensation*

Salary$555,000
Total Annual Compensation$555,000

Stock Options*

Exercisable Options304,965
Exercisable Options Value$19,063
Unexercisable Options176,696
Unexercisable Options Value$62,604
Total Value of Options$81,666
Total Number of Options481,661

Total Compensation*

Total Annual Cash Compensation$804,750
Total Short Term Compensation$555,000
Total Calculated Compensation$1,322,750
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTK:US $6.14 USD +0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$366.2K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOKINETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.